Marksans Pharma’s arm receives marketing authorization for Baclofen

19 Mar 2025 Evaluate

Marksans Pharma’s wholly owned subsidiary in UK -- Relonchem has received Marketing Authorization for the product Baclofen 10 mg Tablets from UK Medicines and Healthcare Products Regulatory Agency (UK MHRA). 

Earlier, Relonchem had received Marketing Authorization for the product Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets (Bell's Healthcare Dual Action Pain Relief 200 mg/500 mg Film-coated Tablets).

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.


Marksans Pharma Share Price

180.05 1.15 (0.64%)
29-Dec-2025 10:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.40
Dr. Reddys Lab 1266.45
Cipla 1505.95
Zydus Lifesciences 907.65
Lupin 2101.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×